Trastuzumab 600mg /5 mL
Product Overview
| Generic Name | Trastuzumab 600mg /5 mL |
| Brand Name(s) | Herceptin |
| Category | Antibodies, monoclonal |
| Form | Intravenous infusion formulations—lyophilized powder or solution |
| Strength | 600 mg /5mL. |
| Therapeutic Class | Monoclonal antibody targeting HER2/neu (antineoplastic/immunomodulator) |
| ATC Code | L01FD01 |
Manufacturing & Regulatory
| Manufacturer | Roche/Genentech |
| GMP Compliance | WHO-GMP |
| DMF/CEP | Type II |
| COFEPRIS | 010.000.6046.00 |
| Free Sale Certificate | Yes |
Logistics & Export
| MOQ | 10 units |
| Shelf Life | 24 months |
| Storage | 2–8 °C |
| Incoterms | EXW |
| Lead Time | 7 to 10 Days |
Documentation Available Upon Request
| Certificate of Analysis (PDF) | Yes |
| SDS-Safety Data Sheet (PDF) | Upon Request, not publicly posted |
| CTD Summary (PDF) | CTD proprietary; available under commercial agreement/license |